Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Asia-Pacific Journal of Clinical Oncology|October 5, 2010
Sustained long-term remissions with weekly interferon maintenance therapy in hairy cell leukemiaRaj Ramakrishna, Arumugam ManoharanJournal of Hematology|March 1, 2021
Use of a Mobile Intermittent Pneumatic Compression Device (Vekroosan) in Mobile Patients With Chronic Venous DiseaseRaj Ramakrishna, William Alexander, Lina BaytiehJournal of Hematology|August 29, 2020
Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot StudyWilliam Alexander, Sarah Davis, Raj Ramakrishna, et al.Integrative Cancer Therapies|December 21, 2021
Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative ReviewSoo Liang Ooi, Ron Campbell, Sok Cheon Pak, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 23, 2004
Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigationEmmanuel J Favaloro, Jennifer Posen, Raj Ramakrishna, et al.Hemasphere|November 15, 2019
Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES studyP Joy Ho, Devendra Hiwase, Raj Ramakrishna, et al.Neuro-Oncology|August 7, 2008
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cellsClaire Marie-Elisabeth Sauvageot, Jessica Leigh Weatherbee, Santosh Kesari, et al.Cell Reports|July 21, 2017
Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic SyndromesAshwin Unnikrishnan, Elli Papaemmanuil, Dominik Beck, et al.Pageof 1